TherapeuticsMD
TXMD
124 hedge funds and large institutions have $42.6M invested in TherapeuticsMD in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 43 reducing their positions, and 21 closing their positions.
97% more call options, than puts
Call options by funds: $183K | Put options by funds: $93K
0.09% less ownership
Funds ownership: 0.58% → 0.49% (-0.09%)
3% less capital invested
Capital invested by funds: $44M → $42.6M (-$1.48M)
5% less funds holding
Funds holding: 131 → 124 (-7)
29% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 21
40% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.08M |
| 2 |
Goldman Sachs
New York
|
+$791K |
| 3 |
Renaissance Technologies
New York
|
+$702K |
| 4 |
PVI
Pura Vida Investments
New York
|
+$509K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$285K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.3M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.84M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$843K |
| 4 |
D.E. Shaw & Co
New York
|
-$372K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$322K |
TXMD Hedge Fund Activity: Q1 2022 in Review
124 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q1 2022, worth a combined $42.6M — down 3.4% from $44M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of TXMD and 15 opened new positions — a net loss of 6 holders — while 43 trimmed existing stakes and 26 added.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $1.08M. The largest seller was Fidelity Investments, cutting an estimated $4.3M.
- 124 institutional investors held TherapeuticsMD (TXMD) as of Q1 2022, down from 131 in Q4 2021.
- Funds reported $42.6M of TherapeuticsMD stock for Q1 2022, down 3.4% quarter-over-quarter.
- 15 funds opened new TherapeuticsMD positions in Q1 2022 and 21 closed out, a net change of -6 holders.
- The largest TherapeuticsMD buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.08M added.
- The largest TherapeuticsMD seller in Q1 2022 was Fidelity Investments, an estimated $4.3M sold.
Based on aggregated 13F filings for Q1 2022.